Clinical Trial Update: Phase 3 Trial Evaluating Hyperthermic Intraperitoneal Chemotherapy in Upfront Treatment of Stage IIIC Epithelial Ovarian Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating hyperthermic intraperitoneal chemotherapy for upfront treatment of stage IIIC epithelial ovarian cancer is reported; current status is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epithelial Ovarian Cancer
• Ovarian Cancer

Snippet

Sponsor: A.O. Ospedale Papa Giovanni XXIII | Conditions: Ovarian Neoplasms | Phase 3 | Status: UNKNOWN